Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Correction to: Ultra-low-field brain MRI morphometry: Test-retest reliability and correspondence to high-field MRI.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Alzheimer's Imaging Consortium.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Alzheimer's Imaging Consortium.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Manmohi D Dake1,2, Himank Kavathekar1, Ashwin V Venkataraman2,3,4

  • 1Silver Matter, Pune, Maharashtra, India.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

一种新的深度学习方法使用MRI扫描来检测阿尔茨海默病的粉样蛋白病理,为PET扫描提供了更安全,更容易获得的替代方案. 这种方法旨在改善早期诊断和患者的治疗结果.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经成像是一种神经成像.
  • 人工智能在医学中的应用
  • 生物标志物发现发现

背景情况:

  • 传统的阿尔茨海默氏症 (AD) 病理检测方法昂贵,侵入性且难以获得.
  • 早期识别AD生物标志物对于及时干预和改善患者结果至关重要.
  • 开发了一种使用多模态核磁共振 (MRI) 的新,成本效益高,非侵入性方法,用于检测粉样蛋白病理,这是阿尔茨海默症的一个关键标志.

研究的目的:

  • 开发和验证一种深度学习模型,用于使用MRI扫描检测粉样蛋白病理.
  • 为现有的AD生物标志物检测方法提供更安全,更实惠和更容易获得的替代方案.
  • 为了利用常规获得的MRI扫描来提高AD诊断的临床洞察力.

主要方法:

  • 在来自阿尔茨海默病神经成像计划 (ADNI) 的1488个配对粉样蛋白PET和MRI扫描上训练了一种深度学习模型.
  • T1加权和T2加权的MRI扫描作为输入来合成代表粉样蛋白病理的图像.
  • 用验证数据集的灵敏度,特异性和准确度指标评估模型性能,将合成图像SUVR得分与地面真实性PET图像进行比较.

主要成果:

  • 深度学习模型在检测粉样蛋白阳性时,获得了0.70的灵敏度,0.72的特异性和0.71的准确性.
  • 合成图像显示与原始PET图像有很强的对齐,可比的SUVR得分表明了这一点.
  • 该模型在识别粉样蛋白阳性方面表现出临床相关的准确性.

结论:

  • 这项研究提出了一种更安全,更实惠,更容易获得的粉样蛋白检测方法的概念证明.
  • 开发的技术利用标准的MRI扫描来提供非侵入性的洞察力,用于识别早期疾病修饰疗法的候选人.
  • 模型的进一步改进正在进行中,但该方法具有改善早期AD检测和患者预后的巨大潜力.